SIRACUSA
Live / Registered — Registered (as of 10 Mar 2020)
What this means for you
Registered since 10 Mar 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87886335
- Registration number
- 6004952
- Mark type
- Stylized text
- Filed
- 20 Apr 2018
- Published for opposition
- 24 Dec 2019
- Registered
- 10 Mar 2020
- Attorney of record
- Frances M. Jagla
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in oncology, endocrinology, neurology, hematology, gastroenterology, and for cardiovascular and cognitive disorders; pharmaceutical preparations for use in urology; pharmaceutical preparations for the treatment and prevention of neuromuscular disorders, muscle disorders orthopedic disorders, disorders relating to age; pharmaceutical preparations for the treatment of pain, muscle spasm, hemifacial spasm and blepharospasm; pharmaceutical preparations for the treatment and prevention of cervical dystonia, torticollis, cerebral palsy, and spasticity; pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other derivatives for use in the treatment of excessive sweating, neuromuscular disorders, muscle disorders, orthopedic disorders, disorders relating to age, pain, muscle spasm, hemifacial spasm and blepharospasm, cervical dystonia, torticollis, cerebral palsy, and spasticity, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin
- Class 042 — Scientific and technological services: Conducting clinical trials for others for pharmaceuticals; research in the field of pharmaceuticals; scientific research for the purpose of medical evaluations; biological, clinical and medical research; conducting clinical trials for others; providing information in medical and scientific research in the field of pharmaceutical products and clinical trials; conducting tests on pharmaceuticals
Owner
- Ipsen Biopharm Limited, Wrexham, GB
- Ipsen Biopharm Limited, Wrexham, GB
- Ipsen Biopharm Limited, Wrexham, GB
Prosecution history
- 10 Mar 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Mar 2020 — REGISTERED-PRINCIPAL REGISTER
- 24 Dec 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Dec 2019 — PUBLISHED FOR OPPOSITION
- 04 Dec 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Nov 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Nov 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Nov 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Oct 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 May 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 May 2019 — NON-FINAL ACTION E-MAILED
- 05 May 2019 — NON-FINAL ACTION WRITTEN
- 22 Apr 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Apr 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Apr 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED